Cite
HARVARD Citation
Eberhardt, W. et al. (n.d.). Comparative efficacy and safety of nivolumab (nivo) vs relevant treatments (txs) in pretreated squamous (SQ) advanced non-small cell lung cancer (aNSCLC): Results from a systematic literature review (SLR) and indirect treatment comparisons (ITCs) of randomized controlled trials (RCTs). European journal of cancer. pp. S136-. [Online].